With the Market Flashing Warning Signs Not Seen Since the Dot-Com Bust, Is Pfizer's 6% Yield a Safe Haven or a Trap?
Key PointsPfizer is facing several headwinds, which have weighed on its financial results.
With the Market Flashing Warning Signs Not Seen Since the Dot-Com Bust, Is Pfizer's 6% Yield a Safe Haven or a Trap?
Key PointsPfizer is facing several headwinds, which have weighed on its financial results.